Longeveron Inc. (NASDAQ: LGVN) Stock Information | RedChip

Longeveron Inc. (NASDAQ: LGVN) Listen to this Section


$2.34
-0.1200 ( -4.88% ) 573.3K

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

Market Data


Open


$2.34

Previous close


$2.46

Volume


573.3K

Market cap


$33.74M

Day range


$2.31 - $2.48

52 week range


$0.77 - $35.60

Insider Ownership Transactions

Total Amount Purchased: -110,219.00 | $ -257,912.46

Date Type Amount Purchased Purchaser
2023-10-04 Sale -815.00 Lehr Paul T
2023-09-22 Sale -5000.00 Hare Joshua
2023-09-21 Sale -2000.00 Lehr Paul T
2023-09-14 Sale -30000.00 Hare Joshua
2023-09-13 Sale -10000.00 Hashad Mohamed Wa'el Ahmed
2023-09-13 Buy 5000.00 Locklear Lisa
2023-09-13 Sale -30000.00 Hare Joshua
2023-09-12 Sale -30000.00 Soffer Rock
2023-09-06 Sale -4323.00 Hashad Mohamed Wa'el Ahmed
2023-08-22 Sale -3081.00 Agafonova Nataliya

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 14 Mar 07, 2024
10-k Annual reports 118 Feb 27, 2024
8-k 8K-related 14 Feb 22, 2024
def Proxies and info statements 3 Feb 05, 2024
4 Insider transactions 1 Feb 02, 2024
pre Proxies and info statements 3 Jan 25, 2024
4 Insider transactions 1 Jan 25, 2024
4 Insider transactions 1 Jan 25, 2024
4 Insider transactions 1 Jan 25, 2024
4 Insider transactions 1 Jan 25, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.